This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fodor, E.
Right arrow Articles by García-Sastre, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fodor, E.
Right arrow Articles by García-Sastre, A.

 Previous Article  |  Next Article 

Journal of Virology, November 1999, p. 9679-9682, Vol. 73, No. 11
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Rescue of Influenza A Virus from Recombinant DNA

Ervin Fodor,1,2 Louise Devenish,1 Othmar G. Engelhardt,2,dagger Peter Palese,2 George G. Brownlee,1,* and Adolfo García-Sastre2

Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom,1 and Department of Microbiology, Mount Sinai School of Medicine, New York, New York 100292

Received 13 July 1999/Accepted 5 August 1999


    ABSTRACT
Top
Abstract
Text
References

We have rescued influenza A virus by transfection of 12 plasmids into Vero cells. The eight individual negative-sense genomic viral RNAs were transcribed from plasmids containing human RNA polymerase I promoter and hepatitis delta virus ribozyme sequences. The three influenza virus polymerase proteins and the nucleoprotein were expressed from protein expression plasmids. This plasmid-based reverse genetics technique facilitates the generation of recombinant influenza viruses containing specific mutations in their genes.


    TEXT
Top
Abstract
Text
References

Reverse genetics for negative-strand RNA viruses, first developed for influenza virus (8, 22), has dramatically changed our understanding of the replication cycles of these viruses. In addition, this methodology has allowed genetic manipulation of viral genomes in order to generate new viruses, which can be used as live, attenuated vaccines or vectors to express heterologous proteins (12). The past 5 years have witnessed the rescue of most of the important nonsegmented, negative-strand RNA viruses from recombinant DNA. First, Schnell et al. (30) succeeded in the recovery of rabies virus from cloned DNA. Shortly after, rescue systems were developed for vesicular stomatitis virus (21, 32), respiratory syncytial virus (5, 18a), measles virus (29), Sendai virus (14, 20), and more recently for human parainfluenza type 3 (7, 17), rinderpest virus (1), simian virus 5 (16), bovine respiratory syncytial virus (4), and Newcastle disease virus (27). Bridgen and Elliott (3) succeeded in rescuing a segmented, negative-strand RNA virus, a bunyavirus, from cDNA. In general, all these methods rely on intracellular reconstitution of ribonucleoprotein (RNP) complexes from RNA and viral proteins, i.e., nucleoprotein and RNA-dependent RNA polymerase, which are introduced into cells by a variety of techniques. Generally, a recombinant vaccinia virus expressing T7 RNA polymerase is used to drive transcription of antigenomic positive-sense RNA as the template in order to initiate the replication cycle. Alternatively, transcription is driven by a T7 RNA polymerase, which is constitutively expressed in specific cell lines. Successful recoveries have also been reported by directly transfecting naked RNA (plus sense or minus sense) into cells expressing the essential proteins for encapsidation, transcription, and replication (20). Although reverse genetics techniques allowing genetic manipulation of negative-strand RNA viruses were established for influenza A virus before other negative-strand RNA viruses (8, 22, 31), full recovery of infectious influenza virus from cDNA without the use of helper virus has proved to be technically more difficult.

The genome of influenza A virus consists of eight segments of single-stranded, negative-sense RNA (25). The minimal set of viral proteins required for encapsidation, transcription, and replication of the viral genome are the three subunits of the viral RNA-dependent RNA polymerase complex (PB1, PB2, and PA) and the nucleoprotein (NP) (18). Initially, in order to manipulate the genome of influenza virus, RNPs were reconstituted in vitro from RNA transcribed from plasmid DNA in the presence of polymerase proteins and NP isolated from purified influenza virus (8, 9). The in vitro-reconstituted RNPs were transfected into cells infected with a helper influenza virus, which provided the remaining viral proteins and RNA segments, resulting in the generation of transfectant viruses. This technique has been extremely useful in advancing our understanding of the molecular biology and pathogenicity of influenza viruses. However, it relies on highly specialized selection methods to isolate the transfectant viruses from the helper virus, which restricts its use to certain RNA segments of a limited number of viral strains.

More recently, alternative methods for introducing influenza virus RNPs into cells have been developed, based on intracellular reconstitution of RNPs from in vivo-transcribed RNA and intracellularly expressed viral proteins (23, 24, 28, 33). We showed that the three polymerase proteins (PB1, PB2, and PA) and the nucleoprotein (NP) expressed from recombinant plasmids could encapsidate, transcribe, and replicate an influenza virus viral RNA (vRNA)-like RNA containing a chloramphenicol acetyltransferase (CAT) reporter gene in transfected human 293 cells (28). This vRNA-like reporter gene was introduced into the cells by transfection of a plasmid DNA (pPOLI-CAT-RT) with a truncated human RNA polymerase I (Pol I) promoter (nucleotides [nt] -250 to -1) positioned upstream of the vRNA-coding region. The sequence of the hepatitis delta virus genomic ribozyme was positioned downstream of the vRNA-coding region in order to ensure that RNA processing gave the correct 3' end of the vRNA. It has also been demonstrated that, by replacing the plasmid coding for the CAT reporter gene with a plasmid encoding an authentic influenza vRNA segment, intracellularly reconstituted RNP complexes could be rescued into transfectant viruses upon infection of the transfected cells with an influenza helper virus. Thus, helper virus-based rescue systems using the RNA Pol I promoter-driven reverse genetics technique have been established for the segments encoding the neuraminidase (NA), the hemagglutinin (HA), the NS1 and NEP proteins, and the polymerase 2 basic protein (PB2) (11, 13, 26, 28). These results suggested that coexpression of the eight vRNA segments of influenza virus with the three polymerase proteins and the NP might allow rescue of infectious influenza virus from plasmid DNA.

In this report we describe the rescue of influenza A virus from recombinant DNA. The system is entirely plasmid driven and does not involve the use of any helper or heterologous virus (Fig. 1). In order to recover infectious influenza virus from cloned cDNA, we used a mixture of eight plasmids expressing the individual vRNA segments of influenza A/WSN/33 virus from a truncated human Pol I promoter. We also replaced the previously used four protein expression plasmids, which expressed PB1, PB2, PA, and NP under the control of a mouse hydroxymethylglutaryl-coenzyme A reductase (HMG) promoter (28), with plasmids expressing the same proteins under the control of the adenovirus type 2 major late promoter (pGT-h-PB1, pGT-h-PB2, pGT-h-PA, and pGT-h-NP) (2). Cotransfection of these four plasmids with pPOLI-CAT-RT into 293 or Vero cells resulted in CAT expression (results not shown). We decided to use Vero cells for the virus rescue, since they support the growth of influenza A/WSN/33 virus better than 293 cells (about 1 log difference in maximum viral titers) (results not shown).


View larger version (18K):
[in this window]
[in a new window]
  		FIG. 1.   Schematic representation of the plasmid-based rescue system for influenza A virus. The pGT-h set of protein expression plasmids was constructed by inserting the open reading frames of PB1, PB2, PA, and NP proteins into the BclI cloning site of the pGT-h plasmid (2). The PB1 and PA genes were derived from influenza A/WSN/33 virus. The PB2 and NP genes were derived from influenza A/PR/8/34 virus. The viral genomic sequences of influenza A/WSN/33 virus were cloned into pUC18- or pUC19-based plasmids between a truncated human RNA Pol I promoter (nt -250 to -1) (19) and sequences of the hepatitis delta virus ribozyme in an analogous way as described for pPOLI-CAT-RT (28). Genetic tags were inserted into the HA- and NA-encoding plasmids by using conventional mutagenic techniques. For viral rescue, 5 µg of each of the polymerase protein expression plasmids (pGT-h-PB1, pGT-h-PB2, and pGT-h-PA), 10 µg of the NP-expressing pGT-h-NP, and 3 µg of each of the eight vRNA-coding transcription plasmids (pPOLI-PB2-RT, pPOLI-PB1-RT, pPOLI-PA-RT, pPOLI-HA-RT, pPOLI-NP-RT, pPOLI-NA-RT, pPOLI-M-RT, and pPOLI-NS-RT) were diluted to a concentration of 0.1 µg/µl in 20 mM HEPES buffer (pH 7.5). The DNA solution was added to diluted DOTAP liposomal transfection reagent (Boehringer) containing 240 µl of DOTAP and 720 µl of 20 mM HEPES buffer (pH 7.5). The transfection mixture was incubated at room temperature for 15 min, mixed with 6.5 ml of MEM containing 0.5% fetal calf serum, 0.3% bovine serum albumin, penicillin, and streptomycin and added to near-confluent Vero cells washed with phosphate-buffered saline in 8.5-cm dishes (about 107 cells). At 24 h after transfection, the transfection mixture was removed and the cells were incubated with 8 ml of fresh medium, which was replaced daily for 4 days. The harvested medium from transfected dishes was screened for rescued influenza virus by plaquing and amplification on MDBK cells. POL I, truncated human RNA polymerase I promoter; R, genomic hepatitis virus ribozyme; MLP, adenovirus type 2 major late promoter; pA, polyadenylation sequence from SV40.

For virus rescue, near-confluent Vero cells in 8.5-cm-diameter dishes, were cotransfected with the four protein expression plasmids and the eight vRNA transcription plasmids (pPOLI-PB2-RT, pPOLI-PB1-RT, pPOLI-PA-RT, pPOLI-HA-RT, pPOLI-NP-RT, pPOLI-NA-RT, pPOLI-M-RT, and pPOLI-NS-RT). After 24 h, the transfection medium was removed from the cells and it was replaced with 8 ml of fresh medium (MEM) containing 0.5% fetal calf serum, 0.3% bovine serum albumin, penicillin, and streptomycin. The transfected cells were maintained for at least 4 days after transfection. Every day, the medium from the transfected cells was collected and assayed for the presence of influenza virus by plaquing a 0.5-ml aliquot on MDBK cells by standard methods. The rest of the medium was transferred into 75-cm2 flasks of subconfluent MDBK cells for amplification of any rescued virus. This procedure resulted in the recovery of infectious influenza virus on day 4 posttransfection. We obtained about 10 to 20 PFU of virus from an 8.5-cm dish containing approximately 107 cells. The rescued virus showed a specific property which is characteristic of influenza A/WSN/33 virus, i.e., it formed plaques on MDBK cells in the absence of trypsin. The plaques formed by the rescued virus were comparable in size to those formed by an authentic wild-type influenza A/WSN/33 virus grown on the same MDBK cells (results not shown).

To formally prove that the viral plaques observed on MDBK cells were formed by virus derived from the cloned cDNA, we analyzed two of the eight vRNA segments into which genetic tags were introduced. The HA segment contained a mutation of 6 nucleotides near the 3' end of the vRNA (26). Nucleotides 31 to 35 from the 3' end (3'-UUUUG-5') were replaced with 3'-AAAAC-5', resulting in an amino acid substitution at amino acid 4 (Kright-arrowF) and at amino acid 5 (Lright-arrowV) near the N terminus of HA within the signal peptide. In addition, a silent Cright-arrowU mutation was created at nucleotide 40. These changes introduced several new restriction sites, including an SpeI site. The NA segment contained two silent mutations at nucleotides 1358 and 1360, introducing a novel SacI restriction site (28). Medium from MDBK cells infected with the rescued transfectant virus was used to isolate vRNA. Short regions of the HA and NA vRNA containing the genetic tags were amplified by reverse transcription-PCR (RT-PCR) and then analyzed by digestion with SpeI and SacI restriction enzymes, respectively. As a control, the same regions of the HA and NA segments were amplified from vRNA isolated from authentic A/WSN/33 virus using the same RT-PCR primers. As expected, the PCR products obtained from both viruses had identical sizes (Fig. 2, compare lanes 2 and 5 and lanes 7 and 10). Those originating from the HA and the NA segments of the rescued transfectant virus could be digested with SpeI and SacI, respectively (lanes 3 and 8). However, the PCR products from the authentic A/WSN/33 virus were, as expected, not digested (lanes 6 and 11). The omission of reverse transcriptase in control RT-PCR reactions resulted in no visible PCR products (lanes 4 and 9).


View larger version (30K):
[in this window]
[in a new window]
  		FIG. 2.   Demonstration of the presence of genetic tags in the HA and NA vRNA segments of the rescued virus by RT-PCR and restriction enzyme analysis. vRNA of the rescued virus was isolated from medium of infected MDBK cells. One hundred microliters of the medium was treated with 5 U of RNase-free DNase to remove any residual plasmid DNA carried over. After 15 min at 37°C, vRNA was isolated by using the RNeasy Mini Kit (Qiagen), following the manufacturer's instructions. vRNA from authentic wild-type A/WSN/33 virus was isolated from purified virus as described previously (10). The first 149 nt at the 3' end of the HA vRNA were amplified by RT-PCR using oligonucleotide primers 5'-GCGCTCTAGAGCAAAAGCAGGGGAAAATAA-3' (corresponding to nt 1 to 21) and 5'-CGCGAAGCTTCTCGAATATTGTGTCAAC-3' (corresponding to nt 129 to 149), resulting in a 165-nt-long PCR product. To amplify the sequence containing the genetic tag from the NA segment, primers 5'-TGGACTAGTGGGAGCATCAT-3' (corresponding to nt 1280 to 1309) and 5'-GAACAAACTACTTGTCAATGGT-3' (corresponding to nt 1367 to 1388) were used in RT-PCR to produce a 108-nt PCR product. The HA- and NA-specific PCR products were incubated for 2 h at 37°C in the presence (+) or absence (-) of 10 U of SpeI and SacI restriction enzymes, respectively. Samples were analyzed on 16% polyacrylamide gels and stained with ethidium bromide. Lanes: 1, DNA size markers (sizes in nucleotides are indicated); 2, 3, 7, and 8, PCR products from the rescued virus; 4 and 9, control reactions omitting reverse transcriptase; 5, 6, 10, and 11, PCR products from the authentic wild-type A/WSN virus.

It should be pointed out that we have succeeded in recovering influenza virus from plasmids expressing negative-sense vRNA. This seems to contradict some earlier studies, which emphasized the importance of using positive-strand RNA for rescuing negative-strand RNA viruses (3, 29a, 30). However, more recent successful recoveries of negative-strand RNA viruses from negative-sense RNA have been also reported (7, 20). Since at early stages posttransfection, positive-sense mRNA from the four protein expression plasmids coexists with naked negative-sense genomic vRNA transcribed from the transcription plasmids, inevitably double-stranded RNA can form. Formation of double-stranded RNA could lead to the induction of interferon-mediated antiviral responses and consequently to suppression of the growth of any rescued virus. Therefore the use of a cell line, such as Vero, which is known to be deficient in interferon expression (6), might be an important factor for successful virus rescue. Further work, however, is needed to prove this.

At present, we are able to rescue 1 to 2 infectious viral particles from about 106 transfected cells, which corresponds with the "average" recoveries obtained for other negative-strand RNA viruses. By increasing transfection efficiencies and optimizing the ratio of transfected plasmids it might be possible to obtain higher recoveries of virus. Recently, Gómez-Puertas et al. (15) demonstrated that by optimizing plasmid ratios they can significantly increase the formation of influenza virus-like particles from expressed viral proteins. In addition, cell lines expressing essential proteins for encapsidation, transcription, and replication of viral genomic RNA (PB1, PB2, PA, and NP) could help to reduce the number of plasmids needed and thus increase the efficiency of rescue.

In summary, we have rescued a recombinant influenza A virus by cotransfecting eight transcription plasmids for the individual vRNA segments and four protein expression plasmids, entirely from cDNA in the absence of any helper virus. The identity of the rescued virus was confirmed by providing evidence for the presence of two genetic tags in two different genome segments. The development of an entirely plasmid-based rescue system for influenza A virus opens the way for the study of different aspects of influenza virus replication and its interactions with the host cell. In addition, it allows full manipulation of the genome of the virus, which might result in the development of new vaccine strains not only for influenza, but for other infectious agents by introducing specific foreign epitopes into influenza virus proteins. In contrast to the earlier helper virus-based rescue techniques, the plasmid-based system can easily be used for the generation of infectious influenza viruses containing multiple mutations in several different genes at the same time.


    ACKNOWLEDGMENTS

We thank Andrew Gannon, Selvon St. Clair, and Stephan Pleschka for constructing several plasmids. We also thank Leo Poon, Jason Paragas, Thomas Zürcher, Masayoshi Enami, and David Pritlove for helpful discussions and Richard Jaskunas for advice.

This work was supported in part by grants from the MRC (programme grant G9523972 to G.G.B.) and the NIH (P.P. and A.G.-S.). E.F. was supported by the Max Kade Foundation in New York (January 1997 to February 1998) and by the MRC programme grant to G.G.B. in Oxford (March 1998 to the present).


    ADDENDUM IN PROOF

Following submission of this paper, Neumann et al. (G. Neumann, T. Watanabe, H. Ito, S. Watanabe, H. Goto, P. Gao, M. Hughes, D. R. Perez, R. Donis, E. Hoffmann, G. Hobom, and Y. Kawaoka, Proc. Natl. Acad. Sci. USA 96:9345-9350, 1999) provided independent evidence for a plasmid-based rescue of influenza A virus.


    FOOTNOTES

* Corresponding author. Mailing address: Chemical Pathology Unit, Sir William Dunn School of Pathology, University of Oxford, South Parks Rd., Oxford OX1 3RE, United Kingdom. Phone: 44 (01865) 275559. Fax: 44 (1865) 275556. E-mail: George.Brownlee{at}path.ox.ac.uk.

dagger Present address: Department of Virology, University of Freiburg, D-79008 Freiburg, Germany.


    REFERENCES
Top
Abstract
Text
References

1. Baron, M. D., and T. Barrett. 1997. Rescue of rinderpest virus from cloned cDNA. J. Virol. 71:1265-1271[Abstract].
2. Berg, D. T., D. B. McClure, and B. W. Grinnel. 1993. High-level expression of secreted proteins from cells adapted to serum-free suspension culture. BioTechniques 14:972-978[Medline].
3. Bridgen, A., and R. Elliott. 1996. Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs. Proc. Natl. Acad. Sci. USA 93:15400-15404[Abstract/Free Full Text].
4. Buchholz, U. J., S. Finke, and K.-K. Conzelmann. 1999. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J. Virol. 73:251-259[Abstract/Free Full Text].
5. Collins, P. L., M. G. Hill, E. Camargo, H. Grosfeld, R. M. Chanock, and B. R. Murphy. 1995. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc. Natl. Acad. Sci. USA 92:11563-11567[Abstract/Free Full Text].
6. Diaz, M. O., S. Ziemin, M. M. Le Beau, P. Pitha, S. D. Smith, R. R. Chilcote, and J. D. Rowley. 1988. Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc. Natl. Acad. Sci. USA 85:5259-5263[Abstract/Free Full Text].
7. Durbin, A. P., S. L. Hall, J. W. Siew, S. S. Whitehead, P. L. Collins, and B. R. Murphy. 1997. Recovery of infectious human parainfluenza virus type 3 from cDNA. Virology 235:323-332[Medline].
8. Enami, M., W. Luytjes, M. Krystal, and P. Palese. 1990. Introduction of site specific mutations into the genome of influenza virus. Proc. Natl. Acad. Sci. USA 87:3802-3805[Abstract/Free Full Text].
9. Enami, M., and P. Palese. 1991. High-efficiency formation of influenza virus transfectants. J. Virol. 65:2711-2713[Abstract/Free Full Text].
10. Fodor, E., P. Palese, G. G. Brownlee, and A. García-Sastre. 1998. Attenuation of influenza A virus mRNA levels by promoter mutations. J. Virol. 72:6283-6290[Abstract/Free Full Text].
11. Fodor, E., L. Devenish, J. W. McCauley, and W. S. Barclay. Unpublished data.
12. García-Sastre, A. 1998. Negative-strand RNA viruses: applications to biotechnology. Trends Biotechnol. 16:230-235[Medline].
13. García-Sastre, A., A. Egorov, D. Matassov, S. Brandt, D. L. Levy, J. E. Durbin, P. Palese, and T. Muster. 1998. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324-330[Medline].
14. Garcin, D., T. Pelet, P. Calain, L. Roux, J. Curran, and D. Kolakofsky. 1995. A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back non-defective interfering virus. EMBO J. 14:6087-6094[Medline].
15. Gómez-Puertas, P., I. Mena, M. Castillo, A. Vivo, A. Pérez-Pastrana, and A. Portela. 1999. Efficient formation of influenza virus-like particles: dependence on the expression levels of viral proteins. J. Gen. Virol. 80:1635-1645[Abstract].
16. He, B., R. G. Paterson, C. D. Ward, and R. A. Lamb. 1997. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology 237:249-260[Medline].
17. Hoffman, M. A., and A. K. Banrjee. 1997. An infectious clone of human parainfluenza virus type 3. J. Virol. 71:4272-4277[Abstract].
18. Huang, T.-S., P. Palese, and M. Krystal. 1990. Determination of influenza virus proteins required for genome replication. J. Virol. 64:5669-5673[Abstract/Free Full Text].
18a. Jin, H., D. Clarke, H. Z. Zhou, X. Cheng, K. Coelingh, M. Bryant, and S. Li. 1998. Recombinant human respiratory syncytial virus (RSV) from cDNA and construction of subgroup A and B chimeric RSV. Virology 251:206-214[Medline].
19. Jones, M. H., R. M. Learned, and R. Tjian. 1988. Analysis of clustered point mutations in the human ribosomal RNA gene promoter by transient expression in vivo. Proc. Natl. Acad. Sci. USA 85:669-673[Abstract/Free Full Text].
20. Kato, A., Y. Sakai, T. Shioda, T. Kondo, M. Nakanishi, and Y. Nagai. 1996. Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells 1:569-579[Abstract].
21. Lawson, N. D., E. A. Stillman, M. A. Whitt, and J. K. Rose. 1995. Recombinant vesicular stomatitis virus from DNA. Proc. Natl. Acad. Sci. USA 92:4477-4481[Abstract/Free Full Text].
22. Luytjes, W., M. Krystal, M. Enami, J. D. Parvin, and P. Palese. 1989. Amplification, expression, and packaging of a foreign gene by influenza virus. Cell 59:1107-1113[Medline].
23. Neumann, G., and G. Hobom. 1995. Mutational analysis of influenza virus promoter elements in vivo. J. Gen. Virol. 76:1709-1717[Abstract/Free Full Text].
24. Neumann, G., A. Zobel, and G. Hobom. 1994. RNA polymerase I-mediated expression of influenza viral RNA molecules. Virology 202:477-479[Medline].
25. Palese, P. 1977. The genes of influenza virus. Cell 10:1-10[Medline].
26. Palese, P., H. Zheng, O. G. Engelhardt, S. Pleschka, and A. García-Sastre. 1996. Negative-strand RNA viruses: genetic engineering and applications. Proc. Natl. Acad. Sci. USA 93:11354-11358[Abstract/Free Full Text].
27. Peeters, B. P. H., O. S. de Leeuw, G. Koch, and A. L. J. Gielkens. 1999. Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J. Virol. 73:5001-5009[Abstract/Free Full Text].
28. Pleschka, S., S. R. Jaskunas, O. G. Engelhardt, T. Zürcher, P. Palese, and A. García-Sastre. 1996. A plasmid-based reverse genetics system for influenza A virus. J. Virol. 70:4188-4192[Abstract].
29. Radecke, F., P. Spielhofer, H. Schneider, K. Kaelin, M. Huber, C. Dötsch, G. Christiansen, and M. A. Billeter. 1995. Rescue of measles virus from cloned DNA. EMBO J. 14:5773-5784[Medline].
29a. Roberts, A., and J. K. Rose. 1998. Recovery of negative-strand RNA viruses from plasmid DNAs: a positive approach revitalizes a negative field. Virology 247:1-6[Medline].
30. Schnell, M. J., T. Mebatsion, and K. K. Conzelmann. 1994. Infectious rabies viruses from cloned cDNA. EMBO J. 13:4195-4203[Medline].
31. Seong, B. L., and G. G. Brownlee. 1992. A new method for reconstituting influenza polymerase and RNA in vitro: a study of the promoter elements for cRNA and vRNA synthesis in vitro and viral rescue in vivo. Virology 186:247-260[Medline].
32. Whelan, S. P. J., L. A. Ball, J. N. Barr, and G. T. W. Wertz. 1995. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc. Natl. Acad. Sci. USA 92:8388-8392[Abstract/Free Full Text].
33. Zhang, H., and G. M. Air. 1994. Expression of functional influenza virus A polymerase proteins and template from cloned cDNAs in recombinant vaccinia infected cells. Biochem. Biophys. Res. Commun. 200:95-101[Medline].

Journal of Virology, November 1999, p. 9679-9682, Vol. 73, No. 11
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Robb, N. C., Smith, M., Vreede, F. T., Fodor, E. (2009). NS2/NEP protein regulates transcription and replication of the influenza virus RNA genome. J. Gen. Virol. 90: 1398-1407 [Abstract] [Full Text]  
  • Mayrhofer, J., Coulibaly, S., Hessel, A., Holzer, G. W., Schwendinger, M., Bruhl, P., Gerencer, M., Crowe, B. A., Shuo, S., Hong, W., Tan, Y. J., Dietrich, B., Sabarth, N., Savidis-Dacho, H., Kistner, O., Barrett, P. N., Falkner, F. G. (2009). Nonreplicating Vaccinia Virus Vectors Expressing the H5 Influenza Virus Hemagglutinin Produced in Modified Vero Cells Induce Robust Protection. J. Virol. 83: 5192-5203 [Abstract] [Full Text]  
  • Qi, L., Kash, J. C., Dugan, V. G., Wang, R., Jin, G., Cunningham, R. E., Taubenberger, J. K. (2009). Role of Sialic Acid Binding Specificity of the 1918 Influenza Virus Hemagglutinin Protein in Virulence and Pathogenesis for Mice. J. Virol. 83: 3754-3761 [Abstract] [Full Text]  
  • Chaipan, C., Kobasa, D., Bertram, S., Glowacka, I., Steffen, I., Solomon Tsegaye, T., Takeda, M., Bugge, T. H., Kim, S., Park, Y., Marzi, A., Pohlmann, S. (2009). Proteolytic Activation of the 1918 Influenza Virus Hemagglutinin. J. Virol. 83: 3200-3211 [Abstract] [Full Text]  
  • Van Hoeven, N., Pappas, C., Belser, J. A., Maines, T. R., Zeng, H., Garcia-Sastre, A., Sasisekharan, R., Katz, J. M., Tumpey, T. M. (2009). Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc. Natl. Acad. Sci. USA 106: 3366-3371 [Abstract] [Full Text]  
  • Steel, J., Lowen, A. C., Pena, L., Angel, M., Solorzano, A., Albrecht, R., Perez, D. R., Garcia-Sastre, A., Palese, P. (2009). Live Attenuated Influenza Viruses Containing NS1 Truncations as Vaccine Candidates against H5N1 Highly Pathogenic Avian Influenza. J. Virol. 83: 1742-1753 [Abstract] [Full Text]  
  • Rameix-Welti, M.-A., Tomoiu, A., Dos Santos Afonso, E., van der Werf, S., Naffakh, N. (2009). Avian Influenza A Virus Polymerase Association with Nucleoprotein, but Not Polymerase Assembly, Is Impaired in Human Cells during the Course of Infection. J. Virol. 83: 1320-1331 [Abstract] [Full Text]  
  • Jackson, D., Lamb, R. A. (2008). The influenza A virus spliced messenger RNA M mRNA3 is not required for viral replication in tissue culture. J. Gen. Virol. 89: 3097-3101 [Abstract] [Full Text]  
  • Stech, J., Stech, O., Herwig, A., Altmeppen, H., Hundt, J., Gohrbandt, S., Kreibich, A., Weber, S., Klenk, H.-D., Mettenleiter, T. C. (2008). Rapid and reliable universal cloning of influenza A virus genes by target-primed plasmid amplification. Nucleic Acids Res 36: e139-e139 [Abstract] [Full Text]  
  • Daidoji, T., Koma, T., Du, A., Yang, C.-S., Ueda, M., Ikuta, K., Nakaya, T. (2008). H5N1 Avian Influenza Virus Induces Apoptotic Cell Death in Mammalian Airway Epithelial Cells. J. Virol. 82: 11294-11307 [Abstract] [Full Text]  
  • Xu, X., Zhu, X., Dwek, R. A., Stevens, J., Wilson, I. A. (2008). Structural Characterization of the 1918 Influenza Virus H1N1 Neuraminidase. J. Virol. 82: 10493-10501 [Abstract] [Full Text]  
  • Chiang, C., Chen, G.-W., Shih, S.-R. (2008). Mutations at Alternative 5' Splice Sites of M1 mRNA Negatively Affect Influenza A Virus Viability and Growth Rate. J. Virol. 82: 10873-10886 [Abstract] [Full Text]  
  • Hai, R., Martinez-Sobrido, L., Fraser, K. A., Ayllon, J., Garcia-Sastre, A., Palese, P. (2008). Influenza B Virus NS1-Truncated Mutants: Live-Attenuated Vaccine Approach. J. Virol. 82: 10580-10590 [Abstract] [Full Text]  
  • Bouvier, N. M., Lowen, A. C., Palese, P. (2008). Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol. J. Virol. 82: 10052-10058 [Abstract] [Full Text]  
  • Chen, B. J., Leser, G. P., Jackson, D., Lamb, R. A. (2008). The Influenza Virus M2 Protein Cytoplasmic Tail Interacts with the M1 Protein and Influences Virus Assembly at the Site of Virus Budding. J. Virol. 82: 10059-10070 [Abstract] [Full Text]  
  • Vreede, F. T., Gifford, H., Brownlee, G. G. (2008). Role of Initiating Nucleoside Triphosphate Concentrations in the Regulation of Influenza Virus Replication and Transcription. J. Virol. 82: 6902-6910 [Abstract] [Full Text]  
  • Gao, Q., Brydon, E. W. A., Palese, P. (2008). A Seven-Segmented Influenza A Virus Expressing the Influenza C Virus Glycoprotein HEF. J. Virol. 82: 6419-6426 [Abstract] [Full Text]  
  • Huang, I-C., Li, W., Sui, J., Marasco, W., Choe, H., Farzan, M. (2008). Influenza A Virus Neuraminidase Limits Viral Superinfection. J. Virol. 82: 4834-4843 [Abstract] [Full Text]  
  • Jackson, D., Hossain, Md. J., Hickman, D., Perez, D. R., Lamb, R. A. (2008). A new influenza virus virulence determinant: The NS1 protein four C-terminal residues modulate pathogenicity. Proc. Natl. Acad. Sci. USA 105: 4381-4386 [Abstract] [Full Text]  
  • Gao, Q., Park, M.-S., Palese, P. (2008). Expression of Transgenes from Newcastle Disease Virus with a Segmented Genome. J. Virol. 82: 2692-2698 [Abstract] [Full Text]  
  • Marsh, G. A., Rabadan, R., Levine, A. J., Palese, P. (2008). Highly Conserved Regions of Influenza A Virus Polymerase Gene Segments Are Critical for Efficient Viral RNA Packaging. J. Virol. 82: 2295-2304 [Abstract] [Full Text]  
  • Pappas, C., Aguilar, P. V., Basler, C. F., Solorzano, A., Zeng, H., Perrone, L. A., Palese, P., Garcia-Sastre, A., Katz, J. M., Tumpey, T. M. (2008). Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proc. Natl. Acad. Sci. USA 105: 3064-3069 [Abstract] [Full Text]  
  • Murakami, S., Horimoto, T., Yamada, S., Kakugawa, S., Goto, H., Kawaoka, Y. (2008). Establishment of Canine RNA Polymerase I-Driven Reverse Genetics for Influenza A Virus: Its Application for H5N1 Vaccine Production. J. Virol. 82: 1605-1609 [Abstract] [Full Text]  
  • Shen, C.-H., Ge, Q., Talay, O., Eisen, H. N., Garcia-Sastre, A., Chen, J. (2008). Loss of IL-7R and IL-15R Expression Is Associated with Disappearance of Memory T Cells in Respiratory Tract following Influenza Infection. J. Immunol. 180: 171-178 [Abstract] [Full Text]  
  • Owen, R. E., Yamada, E., Thompson, C. I., Phillipson, L. J., Thompson, C., Taylor, E., Zambon, M., Osborn, H. M. I., Barclay, W. S., Borrow, P. (2007). Alterations in Receptor Binding Properties of Recent Human Influenza H3N2 Viruses Are Associated with Reduced Natural Killer Cell Lysis of Infected Cells. J. Virol. 81: 11170-11178 [Abstract] [Full Text]  
  • Crescenzo-Chaigne, B., van der Werf, S. (2007). Rescue of Influenza C Virus from Recombinant DNA. J. Virol. 81: 11282-11289 [Abstract] [Full Text]  
  • Marsh, G. A., Hatami, R., Palese, P. (2007). Specific Residues of the Influenza A Virus Hemagglutinin Viral RNA Are Important for Efficient Packaging into Budding Virions. J. Virol. 81: 9727-9736 [Abstract] [Full Text]  
  • Ozawa, M., Goto, H., Horimoto, T., Kawaoka, Y. (2007). An Adenovirus Vector-Mediated Reverse Genetics System for Influenza A Virus Generation. J. Virol. 81: 9556-9559 [Abstract] [Full Text]  
  • Muraki, Y., Murata, T., Takashita, E., Matsuzaki, Y., Sugawara, K., Hongo, S. (2007). A Mutation on Influenza C Virus M1 Protein Affects Virion Morphology by Altering the Membrane Affinity of the Protein. J. Virol. 81: 8766-8773 [Abstract] [Full Text]  
  • Kochs, G., Garcia-Sastre, A., Martinez-Sobrido, L. (2007). Multiple Anti-Interferon Actions of the Influenza A Virus NS1 Protein. J. Virol. 81: 7011-7021 [Abstract] [Full Text]  
  • de Wit, E., Spronken, M. I. J., Vervaet, G., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., Fouchier, R. A. M. (2007). A reverse-genetics system for Influenza A virus using T7 RNA polymerase. J. Gen. Virol. 88: 1281-1287 [Abstract] [Full Text]  
  • Tumpey, T. M., Maines, T. R., Van Hoeven, N., Glaser, L., Solorzano, A., Pappas, C., Cox, N. J., Swayne, D. E., Palese, P., Katz, J. M., Garcia-Sastre, A. (2007). A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission. Science 315: 655-659 [Abstract] [Full Text]  
  • Ferko, B., Kittel, C., Romanova, J., Sereinig, S., Katinger, H., Egorov, A. (2006). Live Attenuated Influenza Virus Expressing Human Interleukin-2 Reveals Increased Immunogenic Potential in Young and Aged Hosts. J. Virol. 80: 11621-11627 [Abstract] [Full Text]  
  • Wang, S., Taaffe, J., Parker, C., Solorzano, A., Cao, H., Garcia-Sastre, A., Lu, S. (2006). Hemagglutinin (HA) Proteins from H1 and H3 Serotypes of Influenza A Viruses Require Different Antigen Designs for the Induction of Optimal Protective Antibody Responses as Studied by Codon-Optimized HA DNA Vaccines. J. Virol. 80: 11628-11637 [Abstract] [Full Text]  
  • Li, Z., Jiang, Y., Jiao, P., Wang, A., Zhao, F., Tian, G., Wang, X., Yu, K., Bu, Z., Chen, H. (2006). The NS1 Gene Contributes to the Virulence of H5N1 Avian Influenza Viruses. J. Virol. 80: 11115-11123 [Abstract] [Full Text]  
  • Baas, T., Baskin, C. R., Diamond, D. L., Garcia-Sastre, A., Bielefeldt-Ohmann, H., Tumpey, T. M., Thomas, M. J., Carter, V. S., Teal, T. H., Van Hoeven, N., Proll, S., Jacobs, J. M., Caldwell, Z. R., Gritsenko, M. A., Hukkanen, R. R., Camp, D. G. II, Smith, R. D., Katze, M. G. (2006). Integrated Molecular Signature of Disease: Analysis of Influenza Virus-Infected Macaques through Functional Genomics and Proteomics. J. Virol. 80: 10813-10828 [Abstract] [Full Text]  
  • Gillim-Ross, L., Subbarao, K. (2006). Emerging Respiratory Viruses: Challenges and Vaccine Strategies. Clin. Microbiol. Rev. 19: 614-636 [Abstract] [Full Text]  
  • Maines, T. R., Chen, L.-M., Matsuoka, Y., Chen, H., Rowe, T., Ortin, J., Falcon, A., Hien, N. T., Mai, L. Q., Sedyaningsih, E. R., Harun, S., Tumpey, T. M., Donis, R. O., Cox, N. J., Subbarao, K., Katz, J. M. (2006). Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc. Natl. Acad. Sci. USA 103: 12121-12126 [Abstract] [Full Text]  
  • Zamarin, D., Ortigoza, M. B., Palese, P. (2006). Influenza A Virus PB1-F2 Protein Contributes to Viral Pathogenesis in Mice.. J. Virol. 80: 7976-7983 [Abstract] [Full Text]  
  • Park, M.-S., Steel, J., Garcia-Sastre, A., Swayne, D., Palese, P. (2006). From the Cover: Engineered viral vaccine constructs with dual specificity: Avian influenza and Newcastle disease. Proc. Natl. Acad. Sci. USA 103: 8203-8208 [Abstract] [Full Text]  
  • Jung, T. E., Brownlee, G. G. (2006). A new promoter-binding site in the PB1 subunit of the influenza A virus polymerase.. J. Gen. Virol. 87: 679-688 [Abstract] [Full Text]  
  • Tumpey, T. M., Garcia-Sastre, A., Taubenberger, J. K., Palese, P., Swayne, D. E., Pantin-Jackwood, M. J., Schultz-Cherry, S., Solorzano, A., Van Rooijen, N., Katz, J. M., Basler, C. F. (2005). Pathogenicity of Influenza Viruses with Genes from the 1918 Pandemic Virus: Functional Roles of Alveolar Macrophages and Neutrophils in Limiting Virus Replication and Mortality in Mice. J. Virol. 79: 14933-14944 [Abstract] [Full Text]  
  • Neumann, G., Fujii, K., Kino, Y., Kawaoka, Y. (2005). An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proc. Natl. Acad. Sci. USA 102: 16825-16829 [Abstract] [Full Text]  
  • Massin, P., Rodrigues, P., Marasescu, M., van der Werf, S., Naffakh, N. (2005). Cloning of the Chicken RNA Polymerase I Promoter and Use for Reverse Genetics of Influenza A Viruses in Avian Cells. J. Virol. 79: 13811-13816 [Abstract] [Full Text]  
  • Tumpey, T. M., Basler, C. F., Aguilar, P. V., Zeng, H., Solorzano, A., Swayne, D. E., Cox, N. J., Katz, J. M., Taubenberger, J. K., Palese, P., Garcia-Sastre, A. (2005). Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus. Science 310: 77-80 [Abstract] [Full Text]  
  • Falcon, A. M., Fernandez-Sesma, A., Nakaya, Y., Moran, T. M., Ortin, J., Garcia-Sastre, A. (2005). Attenuation and immunogenicity in mice of temperature-sensitive influenza viruses expressing truncated NS1 proteins. J. Gen. Virol. 86: 2817-2821 [Abstract] [Full Text]  
  • de Wit, E., Munster, V. J., Spronken, M. I. J., Bestebroer, T. M., Baas, C., Beyer, W. E. P., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., Fouchier, R. A. M. (2005). Protection of Mice against Lethal Infection with Highly Pathogenic H7N7 Influenza A Virus by Using a Recombinant Low-Pathogenicity Vaccine Strain. J. Virol. 79: 12401-12407 [Abstract] [Full Text]  
  • Li, Z., Chen, H., Jiao, P., Deng, G., Tian, G., Li, Y., Hoffmann, E., Webster, R. G., Matsuoka, Y., Yu, K. (2005). Molecular Basis of Replication of Duck H5N1 Influenza Viruses in a Mammalian Mouse Model. J. Virol. 79: 12058-12064 [Abstract] [Full Text]  
  • Perez, M., de la Torre, J. C. (2005). Identification of the Borna disease virus (BDV) proteins required for the formation of BDV-like particles. J. Gen. Virol. 86: 1891-1895 [Abstract] [Full Text]  
  • Quinlivan, M., Zamarin, D., Garcia-Sastre, A., Cullinane, A., Chambers, T., Palese, P. (2005). Attenuation of Equine Influenza Viruses through Truncations of the NS1 Protein. J. Virol. 79: 8431-8439 [Abstract] [Full Text]  
  • Bourmakina, S. V., Garcia-Sastre, A. (2005). The Morphology and Composition of Influenza A Virus Particles Are Not Affected by Low Levels of M1 and M2 Proteins in Infected Cells. J. Virol. 79: 7926-7932 [Abstract] [Full Text]  
  • Maeda, Y., Hatta, M., Takada, A., Watanabe, T., Goto, H., Neumann, G., Kawaoka, Y. (2005). Live Bivalent Vaccine for Parainfluenza and Influenza Virus Infections. J. Virol. 79: 6674-6679 [Abstract] [Full Text]  
  • Cheung, T. K. W., Guan, Y., Ng, S. S. F., Chen, H., Wong, C. H. K., Peiris, J. S. M., Poon, L. L. M. (2005). Generation of recombinant influenza A virus without M2 ion-channel protein by introduction of a point mutation at the 5' end of the viral intron. J. Gen. Virol. 86: 1447-1454 [Abstract] [Full Text]  
  • Abed, Y., Goyette, N., Boivin, G. (2005). Generation and Characterization of Recombinant Influenza A (H1N1) Viruses Harboring Amantadine Resistance Mutations. Antimicrob. Agents Chemother. 49: 556-559 [Abstract] [Full Text]  
  • Imai, M., Watanabe, S., Ninomiya, A., Obuchi, M., Odagiri, T. (2004). Influenza B Virus BM2 Protein Is a Crucial Component for Incorporation of Viral Ribonucleoprotein Complex into Virions during Virus Assembly. J. Virol. 78: 11007-11015 [Abstract] [Full Text]  
  • Baskin, C. R., Garcia-Sastre, A., Tumpey, T. M., Bielefeldt-Ohmann, H., Carter, V. S., Nistal-Villan, E., Katze, M. G. (2004). Integration of Clinical Data, Pathology, and cDNA Microarrays in Influenza Virus-Infected Pigtailed Macaques (Macaca nemestrina). J. Virol. 78: 10420-10432 [Abstract] [Full Text]  
  • Lipatov, A. S., Govorkova, E. A., Webby, R. J., Ozaki, H., Peiris, M., Guan, Y., Poon, L., Webster, R. G. (2004). Influenza: Emergence and Control. J. Virol. 78: 8951-8959 [Full Text]  
  • Vreede, F. T., Jung, T. E., Brownlee, G. G. (2004). Model Suggesting that Replication of Influenza Virus Is Regulated by Stabilization of Replicative Intermediates. J. Virol. 78: 9568-9572 [Abstract] [Full Text]  
  • Muraki, Y., Washioka, H., Sugawara, K., Matsuzaki, Y., Takashita, E., Hongo, S. (2004). Identification of an amino acid residue on influenza C virus M1 protein responsible for formation of the cord-like structures of the virus. J. Gen. Virol. 85: 1885-1893 [Abstract] [Full Text]  
  • Tumpey, T. M., Garcia-Sastre, A., Taubenberger, J. K., Palese, P., Swayne, D. E., Basler, C. F. (2004). Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc. Natl. Acad. Sci. USA 101: 3166-3171 [Abstract] [Full Text]  
  • Ozaki, H., Govorkova, E. A., Li, C., Xiong, X., Webster, R. G., Webby, R. J. (2004). Generation of High-Yielding Influenza A Viruses in African Green Monkey Kidney (Vero) Cells by Reverse Genetics. J. Virol. 78: 1851-1857 [Abstract] [Full Text]  
  • Jin, H., Zhou, H., Lu, B., Kemble, G. (2004). Imparting Temperature Sensitivity and Attenuation in Ferrets to A/Puerto Rico/8/34 Influenza Virus by Transferring the Genetic Signature for Temperature Sensitivity from Cold-Adapted A/Ann Arbor/6/60. J. Virol. 78: 995-998 [Abstract] [Full Text]  
  • Harvey, R., Martin, A. C. R., Zambon, M., Barclay, W. S. (2004). Restrictions to the Adaptation of Influenza A Virus H5 Hemagglutinin to the Human Host. J. Virol. 78: 502-507 [Abstract] [Full Text]  
  • Donelan, N. R., Basler, C. F., Garcia-Sastre, A. (2003). A Recombinant Influenza A Virus Expressing an RNA-Binding-Defective NS1 Protein Induces High Levels of Beta Interferon and Is Attenuated in Mice. J. Virol. 77: 13257-13266 [Abstract] [Full Text]  
  • Flandorfer, A., Garcia-Sastre, A., Basler, C. F., Palese, P. (2003). Chimeric Influenza A Viruses with a Functional Influenza B Virus Neuraminidase or Hemagglutinin. J. Virol. 77: 9116-9123 [Abstract] [Full Text]  
  • Efferson, C. L., Schickli, J., Ko, B. K., Kawano, K., Mouzi, S., Palese, P., Garcia-Sastre, A., Ioannides, C. G. (2003). Activation of Tumor Antigen-Specific Cytotoxic T Lymphocytes (CTLs) by Human Dendritic Cells Infected with an Attenuated Influenza A Virus Expressing a CTL Epitope Derived from the HER-2/neu Proto-Oncogene. J. Virol. 77: 7411-7424 [Abstract] [Full Text]  
  • Fechter, P., Mingay, L., Sharps, J., Chambers, A., Fodor, E., Brownlee, G. G. (2003). Two Aromatic Residues in the PB2 Subunit of Influenza A RNA Polymerase Are Crucial for Cap Binding. J. Biol. Chem. 278: 20381-20388 [Abstract] [Full Text]  
  • Hatta, M., Kawaoka, Y. (2003). The NB Protein of Influenza B Virus Is Not Necessary for Virus Replication In Vitro. J. Virol. 77: 6050-6054 [Abstract] [Full Text]  
  • Fodor, E., Mingay, L. J., Crow, M., Deng, T., Brownlee, G. G. (2003). A Single Amino Acid Mutation in the PA Subunit of the Influenza Virus RNA Polymerase Promotes the Generation of Defective Interfering RNAs. J. Virol. 77: 5017-5020 [Abstract] [Full Text]  
  • Catchpole, A. P., Mingay, L. J., Fodor, E., Brownlee, G. G. (2003). Alternative base pairs attenuate influenza A virus when introduced into the duplex region of the conserved viral RNA promoter of either the NS or the PA gene. J. Gen. Virol. 84: 507-515 [Abstract] [Full Text]  
  • Bourmakina, S. V., Garcia-Sastre, A. (2003). Reverse genetics studies on the filamentous morphology of influenza A virus. J. Gen. Virol. 84: 517-527 [Abstract] [Full Text]  
  • Wang, X., Basler, C. F., Williams, B. R. G., Silverman, R. H., Palese, P., Garcia-Sastre, A. (2002). Functional Replacement of the Carboxy-Terminal Two-Thirds of the Influenza A Virus NS1 Protein with Short Heterologous Dimerization Domains. J. Virol. 76: 12951-12962 [Abstract] [Full Text]  
  • Neumann, G., Whitt, M. A., Kawaoka, Y. (2002). A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?. J. Gen. Virol. 83: 2635-2662 [Abstract] [Full Text]  
  • Tumpey, T. M., Garcia-Sastre, A., Mikulasova, A., Taubenberger, J. K., Swayne, D. E., Palese, P., Basler, C. F. (2002). Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proc. Natl. Acad. Sci. USA 99: 13849-13854 [Abstract] [Full Text]  
  • Jackson, D., Cadman, A., Zurcher, T., Barclay, W. S. (2002). A Reverse Genetics Approach for Recovery of Recombinant Influenza B Viruses Entirely from cDNA. J. Virol. 76: 11744-11747 [Abstract] [Full Text]  
  • Hoffmann, E., Mahmood, K., Yang, C.-F., Webster, R. G., Greenberg, H. B., Kemble, G. (2002). Rescue of influenza B virus from eight plasmids. Proc. Natl. Acad. Sci. USA 99: 11411-11416 [Abstract] [Full Text]  
  • Fodor, E., Crow, M., Mingay, L. J., Deng, T., Sharps, J., Fechter, P., Brownlee, G. G. (2002). A Single Amino Acid Mutation in the PA Subunit of the Influenza Virus RNA Polymerase Inhibits Endonucleolytic Cleavage of Capped RNAs. J. Virol. 76: 8989-9001 [Abstract] [Full Text]  
  • Brownlee, G. G., Sharps, J. L. (2002). The RNA Polymerase of Influenza A Virus Is Stabilized by Interaction with Its Viral RNA Promoter. J. Virol. 76: 7103-7113 [Abstract] [Full Text]  
  • Bancroft, C. T., Parslow, T. G. (2002). Evidence for Segment-Nonspecific Packaging of the Influenza A Virus Genome. J. Virol. 76: 7133-7139 [Abstract] [Full Text]  
  • Portela, A., Digard, P. (2002). The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J. Gen. Virol. 83: 723-734 [Abstract] [Full Text]  
  • Duhaut, S. D., Dimmock, N. J. (2002). Defective segment 1 RNAs that interfere with production of infectious influenza A virus require at least 150 nucleotides of 5' sequence: evidence from a plasmid-driven system. J. Gen. Virol. 83: 403-411 [Abstract] [Full Text]  
  • Ferko, B., Stasakova, J., Sereinig, S., Romanova, J., Katinger, D., Niebler, B., Katinger, H., Egorov, A. (2001). Hyperattenuated Recombinant Influenza A Virus Nonstructural-Protein-Encoding Vectors Induce Human Immunodeficiency Virus Type 1 Nef-Specific Systemic and Mucosal Immune Responses in Mice. J. Virol. 75: 8899-8908 [Abstract] [Full Text]  
  • Wagner, E., Engelhardt, O. G., Gruber, S., Haller, O., Kochs, G. (2001). Rescue of Recombinant Thogoto Virus from Cloned cDNA. J. Virol. 75: 9282-9286 [Abstract] [Full Text]  
  • Goto, H., Wells, K., Takada, A., Kawaoka, Y. (2001). Plasminogen-Binding Activity of Neuraminidase Determines the Pathogenicity of Influenza A Virus. J. Virol. 75: 9297-9301 [Abstract] [Full Text]  
  • Schultz-Cherry, S., Dybdahl-Sissoko, N., Neumann, G., Kawaoka, Y., Hinshaw, V. S. (2001). Influenza Virus NS1 Protein Induces Apoptosis in Cultured Cells. J. Virol. 75: 7875-7881 [Abstract] [Full Text]  
  • Perez, D. R., Donis, R. O. (2001). Functional Analysis of PA Binding by Influenza A Virus PB1: Effects on Polymerase Activity and Viral Infectivity. J. Virol. 75: 8127-8136 [Abstract] [Full Text]  
  • Paragas, J., Talon, J., O'Neill, R. E., Anderson, D. K., Garcia-Sastre, A., Palese, P. (2001). Influenza B and C Virus NEP (NS2) Proteins Possess Nuclear Export Activities. J. Virol. 75: 7375-7383 [Abstract] [Full Text]  
  • Tourdot, S., Herath, S., Gould, K. G. (2001). Characterization of a new H-2Dk-restricted epitope prominent in primary influenza A virus infection. J. Gen. Virol. 82: 1749-1755 [Abstract] [Full Text]  
  • Watanabe, T., Watanabe, S., Ito, H., Kida, H., Kawaoka, Y. (2001). Influenza A Virus Can Undergo Multiple Cycles of Replication without M2 Ion Channel Activity. J. Virol. 75: 5656-5662 [Abstract] [Full Text]  
  • Yao, Y., Mingay, L. J., McCauley, J. W., Barclay, W. S. (2001). Sequences in Influenza A Virus PB2 Protein That Determine Productive Infection for an Avian Influenza Virus in Mouse and Human Cell Lines. J. Virol. 75: 5410-5415 [Abstract] [Full Text]  
  • Hughes, M. T., McGregor, M., Suzuki, T., Suzuki, Y., Kawaoka, Y. (2001). Adaptation of Influenza A Viruses to Cells Expressing Low Levels of Sialic Acid Leads to Loss of Neuraminidase Activity. J. Virol. 75: 3766-3770 [Abstract] [Full Text]  
  • Basler, C. F., Reid, A. H., Dybing, J. K., Janczewski, T. A., Fanning, T. G., Zheng, H., Salvatore, M., Perdue, M. L., Swayne, D. E., Garcia-Sastre, A., Palese, P., Taubenberger, J. K. (2001). From the Cover: Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc. Natl. Acad. Sci. USA 98: 2746-2751 [Abstract] [Full Text]  
  • Flick, R., Pettersson, R. F. (2001). Reverse Genetics System for Uukuniemi Virus (Bunyaviridae): RNA Polymerase I-Catalyzed Expression of Chimeric Viral RNAs. J. Virol. 75: 1643-1655 [Abstract] [Full Text]  
  • Wang, X., Li, M., Zheng, H., Muster, T., Palese, P., Beg, A. A., García-Sastre, A. (2000). Influenza A Virus NS1 Protein Prevents Activation of NF-kappa B and Induction of Alpha/Beta Interferon. J. Virol. 74: 11566-11573 [Abstract] [Full Text]  
  • Hoffmann, E., Webster, R. G. (2000). Unidirectional RNA polymerase I-polymerase II transcription system for the generation of influenza A virus from eight plasmids. J. Gen. Virol. 81: 2843-2847 [Abstract] [Full Text]  
  • Wagner, E., Engelhardt, O. G., Weber, F., Haller, O., Kochs, G. (2000). Formation of virus-like particles from cloned cDNAs of Thogoto virus. J. Gen. Virol. 81: 2849-2853 [Abstract] [Full Text]  
  • Zheng, H., Palese, P., García-Sastre, A. (2000). Antitumor Properties of Influenza Virus Vectors. Cancer Res. 60: 6972-6976 [Abstract] [Full Text]  
  • Katz, J. M., Lu, X., Tumpey, T. M., Smith, C. B., Shaw, M. W., Subbarao, K. (2000). Molecular Correlates of Influenza A H5N1 Virus Pathogenesis in Mice. J. Virol. 74: 10807-10810 [Abstract] [Full Text]  
  • Enami, M., Enami, K. (2000). Characterization of Influenza Virus NS1 Protein by Using a Novel Helper-Virus-Free Reverse Genetic System. J. Virol. 74: 5556-5561 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fodor, E.
Right arrow Articles by García-Sastre, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fodor, E.
Right arrow Articles by García-Sastre, A.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»